REV 5901 is a competitive and orally active antagonist of leukotriene receptor, with a Ki of 0.7 µM. REV 5901 is also a 5-lipoxygenase inhibitor. REV 5901 can be used for the research of asthma in which leukotriene release be involved. REV 5901 can be used for the study of colon carcinoma[1][2][3].
Molecular Weight:
335.44
Purity:
99
CAS Number:
[101910-24-1]
Formula:
C22H25NO2
Target:
Leukotriene Receptor,Lipoxygenase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
